There are goof-balls here that don't know the difference between Breakthrough Pain and otherwise "pain" associated with the progression of certain cancers. The relative ignorance of some who post here is documented time and again. What Abstral is able to achieve in managing pain is worlds apart from the otherwise "standard" or "typical" applications of the many other Fentanyl formulations. Does this imply that Abstral and Abstral alone is able to provide rapid pain relief? Absolutely not the case. However, Abstral has been well received throughout Europe and may, therefore, be expected to perform well as a temporary supplemental pain remedy within the US.
Dumbtard. Tell us how Galena is going to COMMERCIALIZE the Abstral product they licensed? Are they going to have to do another financing in order to COMMERCIALIZE or are they going partner with someone who will the COMMERCIALIZATION.